Stevenage Bioscience Catalyst (SBC) has welcomed Inspira Pharmaceuticals to its Lab Hotel, a unique facility offering free lab and office accommodation for six months. The start-ups receive scientific and business support, access to SBC’s networks and introductions to investors to help their business grow and develop.
Rory McGoldrick, co-founder and CEO of Inspira said, “Being selected for the SBC Lab Hotel has provided Inspira with an incredible springboard to achieve our research goals. As a small biotech start-up, making the transition to running our own dedicated lab facilities and building an in-house team is a daunting challenge. With the support of the Lab Hotel we have been able to quickly set up a professional base in the middle of the UK's life-sciences "golden triangle” with access to SBC's state-of-the-art lab facilities and shared infrastructure. We are very grateful for this opportunity which will allow us to rapidly progress our research and prepare for our next big step forward.”
As part of its commitment to supporting early-stage start-ups, SBC opened the Lab Hotel in 2020. Its purpose is to support start-ups working in advanced therapeutics and drug discovery to develop their innovations and secure their next round of funding.
Dr Sally Ann Forsyth OBE, CEO at SBC, said, “Providing support for the translation and commercialisation of early-stage research is part of SBC’s vision. We are delighted to welcome Inspira to the Lab Hotel which gives young life sciences companies access to the facilities and support they need to take their innovative ideas to the next stage.”
The Lab Hotel can accommodate up to four start-up companies for six months at any one time. Having benefitted from the Lab Hotel, many existing occupiers have expanded into larger lab and office space within SBC.
SBC is a leading location for the development and commercialisation of cutting-edge therapeutics. Around 45 life sciences companies are based at the SBC campus, creating an exciting, knowledgeable and collegiate community where interaction and collaboration are the norm.
To find out more about the Lab Hotel or make an application, see SBC’s website or email email@example.com.
About Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst is a world-leading science park of global significance and located at the centre of the largest cluster of cell and gene therapy companies in Europe. It provides a supportive environment to help companies grow by providing access to specialist equipment, mentoring and finance suited to their stage of development. Since its opening in 2012, occupier companies have secured £2.9bn in finance making the cluster one of the most attractive for investment in biotechnology in the UK.
About Inspira Pharmaceuticals Limited
Inspira Pharmaceuticals Limited is a UK based company conducting research and development on its IPX enzyme technology which has potential therapeutic applications for respiratory diseases. Inspira’s mission is to develop the technology into approved medicines for the treatment of several target diseases, including viral and bacterial lung infections. With their platform technology, they are striving to improve global health outcomes. Founded in 2020, the Inspira team is working tirelessly to position Inspira as a new force in respiratory disease innovation.
For more information contact: